Sho Kinguchi

846 total citations
51 papers, 538 citations indexed

About

Sho Kinguchi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Sho Kinguchi has authored 51 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 16 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Nephrology. Recurrent topics in Sho Kinguchi's work include Renin-Angiotensin System Studies (11 papers), Hormonal Regulation and Hypertension (9 papers) and Blood Pressure and Hypertension Studies (7 papers). Sho Kinguchi is often cited by papers focused on Renin-Angiotensin System Studies (11 papers), Hormonal Regulation and Hypertension (9 papers) and Blood Pressure and Hypertension Studies (7 papers). Sho Kinguchi collaborates with scholars based in Japan, Singapore and United States. Sho Kinguchi's co-authors include Kouichi Tamura, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, Akio Yamashita, Takahiro Yamaji, Ryu Kobayashi, Kotaro Haruhara, Takayuki Yamada and Yoshiyuki Toya and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Sho Kinguchi

48 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sho Kinguchi Japan	15	155	146	132	113	88	51	538
Takahiro Yamaji Japan	13	81 0.5×	131 0.9×	139 1.1×	107 0.9×	74 0.8×	28	520
Ander Vergara Spain	13	96 0.6×	174 1.2×	157 1.2×	111 1.0×	115 1.3×	22	519
Jaap A. Joles Netherlands	8	87 0.6×	178 1.2×	105 0.8×	84 0.7×	93 1.1×	11	428
Kotaro Haruhara Japan	16	149 1.0×	111 0.8×	286 2.2×	151 1.3×	84 1.0×	73	696
Taiga Hara Japan	16	140 0.9×	196 1.3×	233 1.8×	103 0.9×	142 1.6×	35	684
Christine Houlihan Australia	13	173 1.1×	216 1.5×	235 1.8×	76 0.7×	69 0.8×	25	660
Yi‐Chih Lin Taiwan	7	60 0.4×	140 1.0×	165 1.3×	119 1.1×	77 0.9×	16	483
S-L Wang China	8	111 0.7×	179 1.2×	64 0.5×	96 0.8×	95 1.1×	26	513
Tomohiko Kanaoka Japan	17	345 2.2×	226 1.5×	147 1.1×	142 1.3×	119 1.4×	51	706

Countries citing papers authored by Sho Kinguchi

Since Specialization

Citations

This map shows the geographic impact of Sho Kinguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Kinguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Kinguchi more than expected).

Fields of papers citing papers by Sho Kinguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Kinguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Kinguchi. The network helps show where Sho Kinguchi may publish in the future.

Co-authorship network of co-authors of Sho Kinguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Kinguchi. A scholar is included among the top collaborators of Sho Kinguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Kinguchi. Sho Kinguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Azushima, Kengo, et al.. (2025). Leucine-rich alpha-2-glycoprotein 1 deficiency suppresses ischemia–reperfusion injury-induced renal fibrosis. Scientific Reports. 15(1). 1259–1259. 1 indexed citations

Azushima, Kengo, Kento Kitada, Kazuya Nakagawa, et al.. (2025). Keratinocyte-specific angiotensin II receptor-associated protein deficiency exacerbates angiotensin II-dependent hypertension via activation of the skin renin-angiotensin system. Nature Communications. 16(1). 4789–4789.

Wakui, Hiromichi, Yuki Kawai, Ryu Kobayashi, et al.. (2024). Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study. Journal of Atherosclerosis and Thrombosis. 31(10). 1370–1385. 2 indexed citations

Azushima, Kengo, Takahiro Yamaji, Toru Suzuki, et al.. (2023). Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL/6 strain. Hypertension Research. 47(1). 55–66. 6 indexed citations

Tsukamoto, Shunichiro, Shohei Tanaka, Takayuki Yamada, et al.. (2023). Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 26(1). 262–274. 13 indexed citations

Tsukamoto, Shunichiro, Hiromichi Wakui, Kengo Azushima, et al.. (2023). Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome. European Heart Journal Open. 3(6). oead098–oead098. 2 indexed citations

Minegishi, Shintaro, Sho Kinguchi, Nobuyuki Horita, et al.. (2022). Immune Checkpoint Inhibitors Do Not Increase Short-Term Risk of Hypertension in Cancer Patients: a Systematic Literature Review and Meta-Analysis. Hypertension. 79(11). 2611–2621. 19 indexed citations

Wakui, Hiromichi, Kengo Azushima, Sho Kinguchi, et al.. (2022). SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan. Clinical and Experimental Nephrology. 26(10). 988–996. 7 indexed citations

Tsukamoto, Shunichiro, Shingo Urate, Takayuki Yamada, et al.. (2022). Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology. 13. 885457–885457. 5 indexed citations

10.

Urate, Shingo, Hiromichi Wakui, Kengo Azushima, et al.. (2021). Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice. International Journal of Molecular Sciences. 22(22). 12432–12432. 22 indexed citations

11.

Tsukamoto, Shunichiro, Takayuki Yamada, Kengo Azushima, et al.. (2021). Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis. Clinical Rheumatology. 41(3). 911–919. 29 indexed citations

12.

Ishii, Takeo, Hiromichi Wakui, Shingo Urate, et al.. (2021). Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy. FEBS Open Bio. 11(2). 507–518. 5 indexed citations

13.

Uneda, Kazushi, Yuki Kawai, Takayuki Yamada, et al.. (2021). Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients. Scientific Reports. 11(1). 10166–10166. 16 indexed citations

14.

Tsukamoto, Shunichiro, Hiromichi Wakui, Kengo Azushima, et al.. (2021). Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease. Scientific Reports. 11(1). 16843–16843. 7 indexed citations

15.

Kinguchi, Sho, Hiromichi Wakui, Yuzuru Ito, et al.. (2021). Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease. Scientific Reports. 11(1). 951–951. 6 indexed citations

16.

Ohki, Kohji, Hiromichi Wakui, Kazushi Uneda, et al.. (2020). Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia. SHILAP Revista de lepidopterología. 6(4). 299–308. 4 indexed citations

17.

Haku, Sona, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice. BioMed Research International. 2018. 1–9. 24 indexed citations

18.

Ohki, Kohji, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue. Scientific Reports. 8(1). 2846–2846. 18 indexed citations

19.

Kobayashi, Ryu, Hiromichi Wakui, Kengo Azushima, et al.. (2017). An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model. Kidney International. 91(5). 1115–1125. 29 indexed citations

20.

Ohsawa, Masato, Kouichi Tamura, Hiromichi Wakui, et al.. (2015). Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia. Lipids in Health and Disease. 14(1). 161–161. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact